Saul W Brusilow

Title: The Innovations of Saul W Brusilow

Introduction

Saul W Brusilow is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of medical science. He holds a total of 8 patents, showcasing his innovative approach to addressing various health conditions through novel methods and compounds.

Latest Patents

One of his latest patents is titled "Modulation of protein expression using carbocyclic aryl alkenoic acid derivatives." This invention relates to diseases or conditions that are influenced by undesired protein expression. The methods described provide for the administration of a therapeutically effective amount of a carbocyclic aryl compound to a mammal, particularly a human, to modulate that undesired protein expression. Additionally, assays for detecting compounds with desired therapeutic capacity are included.

Another significant patent is "Dosage form of L-Methionine S-Sulfoximine." This patent outlines methods for treating diseases that are susceptible to the inhibition of mammalian glutamine synthetase and progressive hyperammonemic encephalopathy. It details the administration of L-methionine S-sulfoxime at specific dosages, emphasizing the importance of not exceeding 10 mg/kg body weight, with preferred dosages being lower.

Career Highlights

Throughout his career, Saul W Brusilow has worked with various organizations, including Brusilow Enterprises LLC and The Johns Hopkins University. His work has significantly impacted the medical field, particularly in developing therapeutic methods for complex diseases.

Collaborations

Saul has collaborated with esteemed colleagues such as Mark L Batshaw and Norman S Radin, contributing to advancements in medical research and innovation.

Conclusion

Saul W Brusilow's innovative work and numerous patents reflect his dedication to improving health outcomes through scientific research. His contributions continue to influence the medical community and inspire future innovations.